INTERLEUKIN-8 STIMULATES ANGIOGENESIS IN RATS

被引:172
作者
HU, DE [1 ]
HORI, Y [1 ]
FAN, TPD [1 ]
机构
[1] UNIV CAMBRIDGE,DEPT PHARMACOL,TENNIS COURT RD,CAMBRIDGE CB2 1QJ,ENGLAND
基金
英国惠康基金;
关键词
D O I
10.1007/BF00916100
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
To test the hypothesis that the cytokines interleukin-6 (IL-6) and IL-8 may play regulatory roles in the aberrant neovascularization in chronic inflammatory diseases, we examined their effects in a rat sponge model and compared their actions with those of IL-1 and tumor necrosis factor-alpha (TNF-alpha). Daily doses of 3 pmol IL-8, IL-1, TNF-alpha, but not IL-6, significantly accelerated the sponge-induced angiogenesis. Although lower doses (0.3 pmol) of these cytokines were inactive, IL-1 acted synergistically with subthreshold daily doses (10 pmol) of substance P (SP) and bradykinin (BK) to produce an intense angiogenic response. In contrast, IL-8 only interacted positively with IL-1, but not TNF-alpha, SP, or BK. There was no synergism or antagonism between IL-6 and SP. These results demonstrate the discrete interactions between angiogenic factors and cytokines in chronic inflammation and suggest that the sponge model is a good means for the study of such interactions.
引用
收藏
页码:135 / 143
页数:9
相关论文
共 19 条
[1]  
ANDRADE SP, 1987, BRIT J EXP PATHOL, V68, P755
[2]  
BROWN RA, 1980, LANCET, V1, P682
[3]  
DETMAR M, 1992, INVEST DERMATOL, V98, P147
[4]  
ENDO H, 1991, LYMPHOKINE CYTOK RES, V10, P245
[5]   ANGIOGENIC FACTORS [J].
FOLKMAN, J ;
KLAGSBRUN, M .
SCIENCE, 1987, 235 (4787) :442-447
[6]   INTERLEUKIN-1 ACTIVITY IN THE SYNOVIAL-FLUID OF PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
FONTANA, A ;
HENGARTNER, H ;
WEBER, E ;
FEHR, K ;
GROB, PJ ;
COHEN, G .
RHEUMATOLOGY INTERNATIONAL, 1982, 2 (02) :49-53
[7]  
FORD HR, 1989, ARCH SURG-CHICAGO, V124, P1422
[8]   BIOLOGICAL AND CLINICAL ASPECTS OF INTERLEUKIN-6 [J].
HIRANO, T ;
AKIRA, S ;
TAGA, T ;
KISHIMOTO, T .
IMMUNOLOGY TODAY, 1990, 11 (12) :443-449
[9]  
HOPKINS SJ, 1988, CLIN EXP IMMUNOL, V73, P88
[10]  
HU DE, 1992, BRIT J PHARMACOL, V106, pP102